Related Experiment Video
Updated: May 6, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Outcomes of Deferring Percutaneous Coronary Intervention Without Physiologic Assessment for Intermediate Coronary
Jihoon Kim1, Seong-Hoon Lim2, Joo-Yong Hahn3
1Division of Cardiology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Insights
Deferring percutaneous coronary intervention (PCI) for intermediate coronary lesions without physiologic assessment led to more major adverse cardiac events (MACE) at 3 years. Medical therapy alone increased revascularization needs compared to PCI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- Outcomes of deferring percutaneous coronary intervention (PCI) for intermediate coronary lesions without invasive physiologic assessment remain uncertain.
- Intermediate coronary lesions are defined as 50-70% diameter stenosis by angiography.
Purpose of the Study:
- To compare long-term outcomes between medical treatment and PCI for intermediate coronary lesions without invasive physiologic assessment.
- To evaluate the risk of major adverse cardiac events (MACE) in patients managed conservatively versus those undergoing PCI.
Main Methods:
- A randomized trial involving 899 patients with intermediate coronary lesions.
- Patients were assigned to a conservative group (deferred PCI) or an aggressive group (PCI performed).
- The primary endpoint was MACE (all-cause death, myocardial infarction, or ischemia-driven revascularization) at 3 years.
Main Results:
- The conservative group had a significantly higher incidence of MACE at 3 years compared to the aggressive group (13.8% vs. 9.3%, p=0.049).
- This difference was primarily driven by increased target intermediate lesion revascularization in the conservative group (6.5% vs. 1.1%, p<0.001).
- The conservative group also showed a higher incidence of cardiac death or MI and ischemia-driven revascularization between 1 and 3 years.
Conclusions:
- Medical therapy alone for intermediate coronary lesions, guided solely by angiography, is associated with a higher risk of MACE at 3 years.
- Performing PCI for intermediate lesions resulted in fewer MACE, mainly due to reduced revascularization needs.
- Invasive physiologic assessment may be crucial for guiding treatment decisions in intermediate coronary lesions.
Background And Objectives:
Outcomes of deferring percutaneous coronary intervention (PCI) without invasive physiologic assessment for intermediate coronary lesions is uncertain. We sought to compare long-term outcomes between medical treatment and PCI of intermediate lesions without invasive physiologic assessment.
Methods:
A total of 899 patients with intermediate coronary lesions between 50% and 70% diameter-stenosis were randomized to the conservative group (n=449) or the aggressive group (n=450). For intermediate lesions, PCI was performed in the aggressive group, but was deferred in the conservative group. The primary endpoint was major adverse cardiac events (MACE, a composite of all-cause death, myocardial infarction [MI], or ischemia-driven any revascularization) at 3 years.
Results:
The number of treated lesions per patient was 0.8±0.9 in the conservative group and 1.7±0.9 in the aggressive group (p=0.001). At 3 years, the conservative group had a significantly higher incidence of MACE than the aggressive group (13.8% vs. 9.3%; hazard ratio [HR], 1.49; 95% confidence interval [CI], 1.00-2.21; p=0.049), mainly driven by revascularization of target intermediate lesion (6.5% vs. 1.1%; HR, 5.69; 95% CI, 2.20-14.73; p<0.001). Between 1 and 3 years after the index procedure, compared to the aggressive group, the conservative group had significantly higher incidence of cardiac death or MI (3.2% vs. 0.7%; HR, 4.34; 95% CI, 1.24-15.22; p=0.022) and ischemia-driven any revascularization.
Conclusions:
For intermediate lesions, medical therapy alone, guided only by angiography, was associated with a higher risk of MACE at 3 years compared with performing PCI, mainly due to increased revascularization.
Trial Registration:
ClinicalTrials.gov Identifier: NCT00743899.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care

